• Content Hubs
    • Bupa
    • UnitedHealthcare Global
  • Supplements
  • About
  • Alerts
  • Advertise
  • Events
  • Research
  • Contact
SUBSCRIBE
No Result
View All Result
Health & Protection
  • PMI & Healthcare
    • Individual
    • SME
    • Large Corporate
    • Cash Plans
    • Hospitals
  • Protection
    • Group Risk
    • Individual Protection
  • International
  • Wellbeing & Mental Health
    • Absence/Productivity
    • Mental Health
    • Services
  • Appointments / Industry
    • Appointments
    • Company News
    • Compliance & Regulation
    • Economy
Health & Protection
No Result
View All Result

The Exeter appoints James Shepherd as non-executive director from Swiss Re

by Graham Simons
08 January 2026
The Exeter appoints James Shepherd as non-executive director from Swiss Re
Share on FacebookShare on Twitter

The Exeter has appointed James Shepherd as a non-executive director, effective from 2 February.

Shepherd (pictured) joins The Exeter board after a four decade-long career covering Swiss Re, GE Capital, ING and Legal & General.

For the last 14 years at Swiss Re he has moved between the roles of COO of the global reinsurance business, serving as chief transformation officer for the group, and leading its global in-force life and health business.

Shepherd said he was thrilled to join the team at The Exeter.

“Peter Hubbard and Isobel Langton have set out to expand what they provide for their members, and I look forward to helping them deliver on this ambition,” he said.

Peter Hubbard, chairman of The Exeter, added: “It’s a privilege to welcome James to the board and to The Exeter.

“He brings an exceptional depth of experience across health and protection, combined with his strong track record in governance, operations and transformation initiatives within our sector.

“As a mutual, our long-term focus is on improving outcomes for our members and supporting advisers in closing the protection gap. James shares that commitment and it will be a pleasure to work closely with him as a board member.”

 

Next Post
Shutterstock

L&G overhauls protection underwriting questions and family medical requests

Cirencester Friendly appoints Waddington as distribution director

Not working due to illness or injury would damage confidence - research

IPMI post-Covid hangover as delayed treatment triggering inflation – Leprêtre

IPMI post-Covid hangover as delayed treatment triggering inflation - Leprêtre

Please login to join discussion

HAVE YOU READ?

Group IPMI dominated by medical inflation and demand for flexibility – analysis

IPMI cost pressures continue but SMEs and non-expat hubs fuel growth – analysis

23 December 2025

Read more

A turbulent year of two halves but health insurance market sees easing inflation ahead – analysis

18 December 2025

Read more
Health & Protection

© 2025 Definite Article Limited. Design by 71 Media Limited.

  • About
  • Advertise
  • Privacy policy
  • Terms & Conditions
  • Contact

Follow Healthcare & Protection

X
No Result
View All Result
  • PMI & Healthcare
    • Individual
    • SME
    • Large Corporate
    • Cash Plans
    • Hospitals
  • Protection
    • Group Risk
    • Individual Protection
  • International
  • Wellbeing & Mental Health
    • Absence/Productivity
    • Mental Health
    • Services
  • Appointments / Industry
    • Appointments
    • Company News
    • Compliance & Regulation
    • Economy

No Result
View All Result
  • PMI & Healthcare
    • Individual
    • SME
    • Large Corporate
    • Cash Plans
    • Hospitals
  • Protection
    • Group Risk
    • Individual Protection
  • International
  • Wellbeing & Mental Health
    • Absence/Productivity
    • Mental Health
    • Services
  • Appointments / Industry
    • Appointments
    • Company News
    • Compliance & Regulation
    • Economy